Black Diamond Therapeutics, Inc. (BDTX)
1.90
+0.05
(+2.70%)
USD |
NASDAQ |
Jun 09, 16:00
1.895
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Shareholders Equity (Quarterly) : 104.30M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Editas Medicine, Inc. | 4.408M |
| Johnson & Johnson | 81.19B |
| Agenus, Inc. | -221.22M |
| Amgen, Inc. | 9.19B |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.92M |
| Total Liabilities (Quarterly) | 28.62M |
| Debt to Equity Ratio | 0.1714 |
| Current Ratio | 8.461 |
| Net Debt Paydown Yield | 0.71% |